Best Medical Robots of 2026: Surgery, Rehab & Hospital Logistics

Medical robots fall into three distinct categories that share a sector label but have almost nothing else in common: different buyers, different budgets, different regulatory frameworks, different clinical evidence requirements, and different procurement timelines.

A hospital CFO evaluating surgical robot capital expenditure and a physiotherapy department evaluating gait rehabilitation equipment are both buying medical robots. They are making entirely different purchasing decisions.

This guide covers the eight leading platforms across surgery, rehabilitation, and hospital logistics. Browse the full Geppetto medical robot category — 15+ platforms tracked with full specs and comparison tools. For workforce implications, see Will Robots Replace Nurses? and Robot Augmentation, Not Replacement.

Three Distinct Categories

Surgical assistance: Robotic systems assisting surgeons in minimally invasive procedures. Capital equipment at $1.5–2.5M+. Buyers are hospital C-suites and surgical programme directors. Regulatory pathway: FDA 510(k) clearance.

Rehabilitation: Exoskeletons and gait trainers assisting patient recovery from neurological injury, stroke, or orthopaedic surgery. $50K–$150K for clinical exoskeletons. Buyers are rehabilitation department heads and physiotherapy managers.

Hospital logistics: Autonomous mobile robots handling internal supply chain tasks. Operational systems with SaaS or service contract models. Buyers are hospital operations and facilities management.

Best Surgical Robot: da Vinci Xi and Its Challenger

Intuitive Surgical da Vinci Xi

The da Vinci Xi is the most deployed surgical robot in history. Over 10 million procedures performed across 7,000+ installed systems globally. That is a clinical evidence base, a trained surgeon network, a service infrastructure, and institutional familiarity that no competitor has matched.

For general surgery, urology, gynaecology, and colorectal procedures, the da Vinci Xi is the default system. A system costs approximately $2M–2.5M capital, with annual service contracts of $100K–$180K and instrument costs of $700–1,500 per procedure.

CMR Surgical Versius

Versius is the most credible challenger. Its modular architecture — each robotic arm is independent — allows hospitals to deploy the number of arms required for their procedure mix, enabling lower entry cost and incremental scaling.

CMR Surgical has grown fastest in UK and European markets where Intuitive's service network is less established. For hospitals outside the US evaluating surgical robotics, Versius warrants serious consideration. For US hospitals with established da Vinci infrastructure and trained surgeons, switching costs in retraining and programme disruption are real.

Compare: da Vinci Xi vs Versius

Best Orthopaedic Surgical Robot: Stryker Mako

Stryker Mako

For knee and hip replacement, Stryker Mako is the category leader with the outcomes data to prove it. CT-based pre-operative planning creates a patient-specific 3D joint model; haptic feedback constrains the surgeon's cutting to planned boundaries. Clinical evidence documents reduced revision rates, more accurate component positioning, and faster patient recovery versus conventional techniques.

Deployed at 1,500+ hospitals globally. For high-volume total joint replacement programmes, Mako's outcomes data and established reimbursement pathways make the procurement case straightforward.

Best Rehabilitation Robots

Hocoma Lokomat — Clinical Gold Standard

For inpatient gait rehabilitation following stroke or spinal cord injury, the Lokomat is the reference system with 400+ peer-reviewed publications. The robotic exoskeleton combined with body weight support guides patients through physiologically accurate gait with precise, repeatable parameter control. No competitor has an equivalent published evidence corpus.

Compare: Lokomat vs ReWalk | Lokomat vs Ekso GT

Ideal for: Neurological rehabilitation units, stroke rehabilitation programmes, spinal cord injury centres.

ReWalk Personal 6.0

ReWalk is a personal exoskeleton for individuals with spinal cord injury using the device for daily ambulation — not clinical sessions. FDA-cleared for home and community use, distinguishing it from clinical-only rehabilitation exoskeletons. Procurement is individual or insurance-funded where reimbursement pathways exist.

Ekso Bionics EksoGT

EksoGT occupies the space between Lokomat and ReWalk: a wearable clinical exoskeleton for hospital rehabilitation with mobility outside the treadmill environment. FDA-cleared for stroke and spinal cord injury rehabilitation, deployed in 300+ rehabilitation hospitals globally. Its advantage is the ability to practise functional gait on varied surfaces and in functional environments.

Best Hospital Logistics Robots

Aethon TUG

Aethon TUG is the most deployed autonomous hospital logistics robot by installed base: 200+ hospitals, over a decade of operational data. The TUG navigates corridors autonomously delivering medications from pharmacy, transporting lab specimens, moving linen and supplies. Integration with pharmacy systems, EHR, and elevator control is mature.

Compare: Aethon TUG vs Moxi

Ideal for: Large acute hospitals with high medication delivery volume and long internal transport distances.

Diligent Robotics Moxi

Moxi is a mobile manipulator with a robotic arm — it can retrieve items from shelves and interact with its environment beyond point-to-point transport. Deployed in 20+ US hospitals, handling supply restocking runs and lab sample transport. Texas Health Resources and others have published data showing meaningful nursing time recovered for direct patient care.

Ideal for: Hospitals seeking broader task automation; deployments where manipulation capability adds value over pure transport.

Medical Robot Procurement: How It Actually Works

Clinical evidence is the first gate. Hospital value analysis committees require peer-reviewed evidence before approving a medical robot. Platforms without established evidence bases face longer, harder approval regardless of technical merit.

Regulatory clearance is mandatory. Every platform on this list has FDA clearance and CE marking for its intended use. Any platform without appropriate regulatory clearance is not a legitimate procurement candidate.

Procurement cycles are long. Surgical robot purchases involve CEO, CFO, surgical programme director, theatre management, finance, and legal. Cycle from initial engagement to contract signature: 12–24 months for capital systems. Hospital logistics: 6–12 months.

Service infrastructure matters as much as hardware. Verify service response commitments, engineer availability, and parts supply chain before finalising any capital purchase.

Training is a programme investment. Surgeon training on da Vinci or Mako is a multi-month commitment representing institutional knowledge and switching cost. Factor this into total cost of ownership.

ROI Framework

Surgical robots: ROI is measured in reduced length of stay, lower complication rates, reduced revision surgery, and programme volume growth. A hospital that can attract minimally invasive surgery volume it previously could not offer has a different ROI calculation than one adding robotic capability to existing open surgery volume.

Rehabilitation robots: ROI is patient throughput per therapist, standardised treatment delivery, and measurable outcome improvement versus conventional therapy. Lokomat studies document faster gait recovery milestones versus conventional overground therapy.

Hospital logistics: ROI is nursing time recovery and logistics efficiency. Studies from TUG and Moxi deployments report 2–4 hours of nursing time recovered per shift per ward. At US nursing costs of $35–45/hr, a multi-robot deployment generates measurable cost offset across a high-volume acute hospital.

Pinocchio's Take

> The da Vinci Xi costs $2M+. CMR Versius costs significantly less and is modular — you deploy the arms you need. For hospitals outside the US where Intuitive's service network is thinner, Versius is worth a serious look. For US hospitals with existing da Vinci infrastructure and trained surgeons, the switching cost is real: surgeon retraining, programme disruption, loss of an evidence base your referrers already trust. The case for Versius in that context is harder to make. > > Stryker Mako does not get the headlines da Vinci does. But for knee and hip replacement specifically, Mako's outcomes data is better than anything else on the market. If your hospital is building joint replacement volume, the Mako decision is straightforward. > > The hospital logistics category is undervalued. TUG and Moxi are not exciting technology — they are operational infrastructure that recovers nursing time for patient care. 200+ hospital deployments for TUG is a track record. The ROI case in high-volume acute hospitals is well-documented.

Prices and deployment availability correct at time of publication.

Frequently Asked Questions

What is the best surgical robot in 2026?

The Intuitive Surgical da Vinci Xi is the most deployed surgical robot globally with 10 million+ procedures across 7,000+ systems. CMR Surgical Versius is the leading challenger, particularly in UK and European markets. For orthopaedic surgery, Stryker Mako leads on outcomes data. See da Vinci Xi vs Versius.

How much does a surgical robot cost?

The da Vinci Xi costs approximately $2M–2.5M in capital with annual service contracts of $100K–$180K and $700–1,500 per procedure in instrument costs. CMR Versius is priced lower with modular structure. Exact pricing requires direct vendor engagement.

What is the difference between Lokomat, ReWalk, and Ekso GT?

Lokomat is a fixed clinical gait rehabilitation system for hospital departments with 400+ peer-reviewed publications. ReWalk Personal 6.0 is a personal wearable exoskeleton for home and community use. EksoGT is a wearable clinical exoskeleton for hospital rehabilitation with community mobility capability. They serve different deployment contexts. See Lokomat vs Ekso GT.

What do hospital logistics robots do?

They automate internal hospital transport: medication delivery from pharmacy, lab specimen transport, linen and supply delivery, supply room restocking. Aethon TUG is deployed in 200+ hospitals for transport tasks. Moxi adds a robotic arm for item retrieval. Both recover nursing time currently spent on routine transport tasks. See TUG vs Moxi.

How long does medical robot procurement take?

Capital surgical systems: 12–24 months from initial vendor engagement to contract. Hospital logistics systems: 6–12 months. Clinical evidence review, value analysis committee approval, IT integration planning, and legal process all contribute.

Are medical robots FDA cleared?

Every platform on this list has FDA clearance for its specific intended use in the US and CE marking for EU markets. FDA clearance for the specific clinical use is a non-negotiable requirement for hospital procurement. Always verify current regulatory status directly with the vendor for your jurisdiction.

What is the ROI case for hospital logistics robots?

Studies from TUG and Moxi deployments report 2–4 hours of nursing time recovered per shift per ward. At US nursing costs of $35–45/hr, a multi-robot deployment across multiple wards generates measurable cost offset in high-volume acute hospitals. Full ROI requires site-specific assessment of delivery volume, corridor distances, staff cost, and integration costs.

Geppetto tracks 15+ medical robot platforms with full specs and comparison tools. Browse all medical robots →